Publication:
Demographic and clinical features of neuromyelitis optica: A review

dc.contributor.authorL. Panditen_US
dc.contributor.authorN. Asgarien_US
dc.contributor.authorM. Apiwattanakulen_US
dc.contributor.authorJ. Palaceen_US
dc.contributor.authorF. Paulen_US
dc.contributor.authorM. I. Leiteen_US
dc.contributor.authorI. Kleiteren_US
dc.contributor.authorT. Chitnisen_US
dc.contributor.authorRaffaele Iorioen_US
dc.contributor.authorJens Würfelen_US
dc.contributor.authorFriedemann Paulen_US
dc.contributor.authorDaniëlle Van Pelten_US
dc.contributor.authorHintzen Rogieren_US
dc.contributor.authorThomas Tedderen_US
dc.contributor.authorAlbert Saizen_US
dc.contributor.authorPablo Villosladaen_US
dc.contributor.authorMichael Levyen_US
dc.contributor.authorLekha Panditen_US
dc.contributor.authorEric Klawiteren_US
dc.contributor.authorBrian Weinshenkeren_US
dc.contributor.authorDean Wingerchuken_US
dc.contributor.authorHo Jin Kimen_US
dc.contributor.authorSilvia Tenembaumen_US
dc.contributor.authorJacqueline Palaceen_US
dc.contributor.authorMaria Isabel Leiteen_US
dc.contributor.authorMetha Apiwattanakulen_US
dc.contributor.authorSimon Broadleyen_US
dc.contributor.authorNaraporn Prayoonwiwaten_US
dc.contributor.authorIngo Kleiteren_US
dc.contributor.authorKerstin Hellwigen_US
dc.contributor.authorMay Hanen_US
dc.contributor.authorBrenda Banwellen_US
dc.contributor.authorKatja Van Herleen_US
dc.contributor.authorAnu Jacoben_US
dc.contributor.authorCraig Hooperen_US
dc.contributor.authorDouglas Kazutoshi Satoen_US
dc.contributor.authorIchiro Nakashimaen_US
dc.contributor.authorKazuo Fujiharaen_US
dc.contributor.authorDenis Bichuettien_US
dc.contributor.authorOrhan Aktasen_US
dc.contributor.authorJerome De Sezeen_US
dc.contributor.authorMichael Yeamanen_US
dc.contributor.authorEmmanuelle Waubanten_US
dc.contributor.authorScott Zamvilen_US
dc.contributor.authorJeffrey Bennetten_US
dc.contributor.authorTerry Smithen_US
dc.contributor.authorMarco Lana-Peixotoen_US
dc.contributor.authorNasrin Asgarien_US
dc.contributor.authorBenjamin Greenbergen_US
dc.contributor.authorOlaf Stuveen_US
dc.contributor.otherK.S. Hegde Medical Academyen_US
dc.contributor.otherSyddansk Universiteten_US
dc.contributor.otherVejle Sygehusen_US
dc.contributor.otherPrasat Neurological Instituteen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherCharité – Universitätsmedizin Berlinen_US
dc.contributor.otherSt. Josef-Hospital im Katholischen Klinikum Bochumen_US
dc.contributor.otherMassachusetts General Hospitalen_US
dc.contributor.otherUniversita Cattolica del Sacro Cuore, Romeen_US
dc.contributor.otherErasmus University Medical Centeren_US
dc.contributor.otherDuke University School of Medicineen_US
dc.contributor.otherInstitut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPSen_US
dc.contributor.otherJohns Hopkins Universityen_US
dc.contributor.otherMayo Clinicen_US
dc.contributor.otherNational Cancer Center, Gyeonggien_US
dc.contributor.otherNational Pediatric Hospital Dr. Juan P. Garrahanen_US
dc.contributor.otherGriffith Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherStanford University School of Medicineen_US
dc.contributor.otherUniversity of Pennsylvaniaen_US
dc.contributor.otherThe Guthy-Jackson Charitable Foundationen_US
dc.contributor.otherNHS Foundation Trusten_US
dc.contributor.otherThomas Jefferson Universityen_US
dc.contributor.otherTohoku Universityen_US
dc.contributor.otherUniversidade Federal de Sao Pauloen_US
dc.contributor.otherHeinrich Heine Universitaten_US
dc.contributor.otherCHU Strasbourgen_US
dc.contributor.otherHarbor-UCLA Medical Centeren_US
dc.contributor.otherUniversity of California, San Franciscoen_US
dc.contributor.otherUniversity of Denveren_US
dc.contributor.otherUniversity of Michigan Medical Schoolen_US
dc.contributor.otherUniversity of Minas Gerais Medical Schoolen_US
dc.contributor.otherUT Southwestern Medical Centeren_US
dc.contributor.otherYale University School of Medicineen_US
dc.date.accessioned2018-11-23T10:42:46Z
dc.date.available2018-11-23T10:42:46Z
dc.date.issued2015-06-06en_US
dc.description.abstract© The Author(s), 2015. The comparative clinical and demographic features of neuromyelitis optica (NMO) are not well known. In this review we analyzed peer-reviewed publications for incidence and prevalence, clinical phenotypes, and demographic features of NMO. Population-based studies from Europe, South East and Southern Asia, the Caribbean, and Cuba suggest that the incidence and prevalence of NMO ranges from 0.05-0.4 and 0.52-4.4 per 100,000, respectively. Mean age at onset (32.6-45.7) and median time to first relapse (8-12 months) was similar. Most studies reported an excess of disease in women and a relapsing course, particularly in anti-aquaporin 4 antibody (anti AQP4-IgG)-positive patients. Ethnicity may have a bearing on disease phenotype and clinical outcome. Despite limitations inherent to the review process, themes noted in clinical and demographic features of NMO among different populations promote a more global understanding of NMO and strategies to address it.en_US
dc.identifier.citationMultiple Sclerosis Journal. Vol.21, No.7 (2015), 845-853en_US
dc.identifier.doi10.1177/1352458515572406en_US
dc.identifier.issn14770970en_US
dc.identifier.issn13524585en_US
dc.identifier.other2-s2.0-84930410893en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/36408
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84930410893&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleDemographic and clinical features of neuromyelitis optica: A reviewen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84930410893&origin=inwarden_US

Files

Collections